Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome.

Eckhard Klieser; Romana Urbas; Stefan Stättner; Florian Primavesi; Tarkan Jäger; Adam Dinnewitzer; Christian Reinhard Mayr; Tobias Kiesslich; Klaus Holzmann; Pietro Di Fazio; Daniel Neureiter; Stefan Swierczynski

doi:10.1016/j.humpath.2017.02.009

Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome.

Eckhard Klieser (Erstautor/-in)
, Romana Urbas (Co-Autor/-in)
, Stefan Stättner
, Florian Primavesi
, Tarkan Jäger (Co-Autor/-in)
, Adam Dinnewitzer (Co-Autor/-in)
, Christian Reinhard Mayr (Co-Autor/-in)
, Tobias Kiesslich (Co-Autor/-in)
, Klaus Holzmann
, Pietro Di Fazio
, Daniel Neureiter^* (Letztautor/-in)
, Stefan Swierczynski (Letztautor/-in)

^*Korrespondierende/r Autor/-in für diese Arbeit

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

51 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	41-52
Fachzeitschrift	HUMAN PATHOLOGY
Jahrgang	65
DOIs	https://doi.org/10.1016/j.humpath.2017.02.009
Publikationsstatus	Veröffentlicht - 2017

Zugriff auf Dokument

10.1016/j.humpath.2017.02.009

Dieses zitieren

Klieser, E., Urbas, R., Stättner, S., Primavesi, F., Jäger, T., Dinnewitzer, A., Mayr, C. R., Kiesslich, T., Holzmann, K., Di Fazio, P., Neureiter, D., & Swierczynski, S. (2017). Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome. HUMAN PATHOLOGY , 65, 41-52. https://doi.org/10.1016/j.humpath.2017.02.009

Klieser, Eckhard ; Urbas, Romana ; Stättner, Stefan et al. / Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome. in: HUMAN PATHOLOGY 2017 ; Jahrgang 65. S. 41-52.

@article{4474d2da1c9343768ec1b1833c9ff038,

title = "Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome.",

keywords = "HUMAN HEPATOCELLULAR-CARCINOMA, CANCER-CELLS, CLINICOPATHOLOGICAL PARAMETERS, DUCTAL ADENOCARCINOMA, 1 EXPRESSION, PROLIFERATION, GROWTH, ACETYLATION, MAINTENANCE, PROGRESSION",

author = "Eckhard Klieser and Romana Urbas and Stefan St{\"a}ttner and Florian Primavesi and Tarkan J{\"a}ger and Adam Dinnewitzer and Mayr, \{Christian Reinhard\} and Tobias Kiesslich and Klaus Holzmann and \{Di Fazio\}, Pietro and Daniel Neureiter and Stefan Swierczynski",

note = "Klieser, Urbas, Neureiter: Paracelsus Med Univ, Inst Pathol, Salzburg, Austria; Jaeger, Dinnewitzer, Swierczynski: Paracelsus Med Univ, Dept Surg, Salzburg, Austria; Mayr, Kiesslich: Paracelsus Med Univ, Dept Internal Med 1, Salzburg, Austria; Mayr, Kiesslich: Paracelsus Med Univ, Inst Physiol \& Pathophysiol, Salzburg, Austria",

year = "2017",

doi = "10.1016/j.humpath.2017.02.009",

language = "English",

volume = "65",

pages = "41--52",

journal = "HUMAN PATHOLOGY ",

issn = "0046-8177",

}

Klieser, E, Urbas, R, Stättner, S, Primavesi, F, Jäger, T, Dinnewitzer, A, Mayr, CR , Kiesslich, T, Holzmann, K, Di Fazio, P, Neureiter, D & Swierczynski, S 2017, 'Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome.', HUMAN PATHOLOGY , Jg. 65, S. 41-52. https://doi.org/10.1016/j.humpath.2017.02.009

Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome. / Klieser, Eckhard (Erstautor/-in); Urbas, Romana (Co-Autor/-in); Stättner, Stefan et al.
in: HUMAN PATHOLOGY , Jahrgang 65, 2017, S. 41-52.

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

TY - JOUR

T1 - Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome.

AU - Klieser, Eckhard

AU - Urbas, Romana

AU - Stättner, Stefan

AU - Primavesi, Florian

AU - Jäger, Tarkan

AU - Dinnewitzer, Adam

AU - Mayr, Christian Reinhard

AU - Kiesslich, Tobias

AU - Holzmann, Klaus

AU - Di Fazio, Pietro

AU - Neureiter, Daniel

AU - Swierczynski, Stefan

N1 - Klieser, Urbas, Neureiter: Paracelsus Med Univ, Inst Pathol, Salzburg, Austria; Jaeger, Dinnewitzer, Swierczynski: Paracelsus Med Univ, Dept Surg, Salzburg, Austria; Mayr, Kiesslich: Paracelsus Med Univ, Dept Internal Med 1, Salzburg, Austria; Mayr, Kiesslich: Paracelsus Med Univ, Inst Physiol & Pathophysiol, Salzburg, Austria

PY - 2017

Y1 - 2017

KW - HUMAN HEPATOCELLULAR-CARCINOMA

KW - CANCER-CELLS

KW - CLINICOPATHOLOGICAL PARAMETERS

KW - DUCTAL ADENOCARCINOMA

KW - 1 EXPRESSION

KW - PROLIFERATION

KW - GROWTH

KW - ACETYLATION

KW - MAINTENANCE

KW - PROGRESSION

U2 - 10.1016/j.humpath.2017.02.009

DO - 10.1016/j.humpath.2017.02.009

M3 - Original Article

C2 - 28235630

SN - 0046-8177

VL - 65

SP - 41

EP - 52

JO - HUMAN PATHOLOGY

JF - HUMAN PATHOLOGY

ER -

Klieser E, Urbas R, Stättner S, Primavesi F, Jäger T, Dinnewitzer A et al. Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome. HUMAN PATHOLOGY . 2017;65:41-52. doi: 10.1016/j.humpath.2017.02.009